Renal Cancers Completed Phase 3 Trials for Medroxyprogesterone acetate (DB00603)

Also known as: Renal Cancer / Kidney Cancer / Renal malignant neoplasm / Renal neoplasms malignant / Cancer of Kidney

IndicationStatusPhase
DBCOND0044624 (Renal Cancers)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00416429Medroxyprogesterone or Interferon and/or Aldesleukin in Treating Patients With Metastatic Kidney CancerTreatment